$DTIL

Precision Biosciences Inc

  • NASDAQ
  • Biotechnology
  • Health Technology

PRICE

$1.61 ▲5.229%

Last Close

VOLUME

5,510,684

DAY RANGE

1.51 - 1.63

52 WEEK

1.11 - 14.38

Join Discuss about DTIL with like-minded investors

profile
@maletone #StockTraders.NET
recently

made some quick coin on that $DTIL move

73 Replies 7 👍 7 🔥

profile
@Baljit123 #StockTraders.NET
recently

Short on DTIL. Missed INMB

76 Replies 10 👍 9 🔥

profile
@dros #droscrew
recently

Downgrades 12/7: $ACN $ATUS $CREE $CRSP $DTIL $FSK $HP $LAD $LBRT $MCD $OXY $RARE $RIG $SIVB $ST $TDOC $VAR

140 Replies 8 👍 14 🔥

Key Metrics

Market Cap

100.10 M

Beta

1.96

Avg. Volume

6.87 M

Shares Outstanding

62.18 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple 'off-the-shelf' CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.

CEO: Matthew Kane

Website:

HQ: 302 E Pettigrew St Ste A100 Durham, 27701-2393 North Carolina

Related News